Watch Ticker

Ocugen, Inc. Common Stock

Go to Ocugen, Inc. Common Stock Website

$1.28

(%)

Live

Previous Close

$1.28

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$329.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, No...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?

Ocugen (OCGN) is expected to provide updates regarding the developmental program of its lead candidate, OCU400, for two rare retinal diseases in the first-quarter earnings release.

Related tickers: ALNY, SRPT, ARGX, OCGN.

Read Full Article

Ocugen - UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa (Phase 3 LiMeliGhT clinical trial), OCU410 for the treatment of geographic atrophy (Phase 1/2 ArMaDa clinical trial), and OCU410ST for the treatment of Stargardt disease (Phase 1/2 GARDian clinical trial) at The Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting in Seattle, WA from May 5-9, 2024.

Related tickers: OCGN.

Read Full Article

Trending Tickers

DATS

XNAS

$1.24

(%)

LASE

XNAS

$2.10

(%)

NYCB

XNYS

$0.00

(%)

PACW

XNAS

$0.00

(%)

MLGO

XNAS

$0.00

(%)